NDC 69336-351

Luvira

Luvira

Luvira is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sterling-knight Pharmaceuticals, Llc. The primary component is Omega-3-acid Ethyl Esters; 12-hydroxyeicosapentaenoic Acid, (12r)-; 4,7,10,13,16,19-docosahexaenoic Acid, (4e,7e,10e,13e,16e,19e)-.

Product ID69336-351_99d7525d-b62e-7f8e-e053-2a95a90a2080
NDC69336-351
Product TypeHuman Prescription Drug
Proprietary NameLuvira
Generic NameLuvira
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-11-07
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSterling-Knight Pharmaceuticals, LLC
Substance NameOMEGA-3-ACID ETHYL ESTERS; 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)-; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)-
Active Ingredient Strength1220 mg/1; mg/1; mg/1
Pharm ClassesFatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC SPL Data Element Entries

NDC 69336-351-90 [69336035190]

Luvira CAPSULE
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-11-07
Marketing End Date2020-01-17

Drug Details

Active Ingredients

IngredientStrength
OMEGA-3-ACID ETHYL ESTERS1220 mg/1

Pharmacological Class

  • Fatty Acids
  • Omega-3 [CS]
  • Omega-3 Fatty Acid [EPC]

NDC Crossover Matching brand name "Luvira" or generic name "Luvira"

NDCBrand NameGeneric Name
69336-349LuviraLuvira
69336-351LuviraLuvira

Trademark Results [Luvira]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LUVIRA
LUVIRA
85244583 4298694 Dead/Cancelled
Zalicus Inc.
2011-02-17
LUVIRA
LUVIRA
77200579 not registered Dead/Abandoned
CombinatoRx, Inc.
2007-06-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.